Browse Category

NASDAQ:GPCR News 13 January 2026 - 15 January 2026

Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

New York, Jan 15, 2026, 13:24 EST — Regular session Pfizer shares edged up roughly 0.3% to $25.67 on Thursday, finding footing after a volatile start to the year. Investors mulled over renewed discussions on U.S. vaccine policy alongside Pfizer’s growth strategy. The stock fluctuated between $25.26 and $25.67, with about 22.3 million shares changing hands. Why it matters now:…
Structure Therapeutics stock jumps as Novo deal talk lifts obesity-drug names

Structure Therapeutics stock jumps as Novo deal talk lifts obesity-drug names

New York, January 14, 2026, 13:46 EST — Regular session Shares of Structure Therapeutics (GPCR) jumped roughly 7.5% Wednesday, as traders returned to small-cap obesity drugmakers. The stock climbed to $83.76, trading over 1 million shares. This shift is crucial as investors wager the weight-loss craze will move from weekly injections to pills, reshaping the buyout landscape. A Novo Nordisk…
Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus

Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus

NEW YORK, Jan 13, 2026, 12:18 EST — Regular session Shares of Structure Therapeutics climbed roughly 14% on Tuesday, adding to the stock’s recent swings. The move came as investors took a fresh look at the company’s newly announced patent licensing deal with Roche’s Genentech. (Reuters) This shift is significant as major drugmakers ramp up their push for obesity pills.…

Stock Market Today

  • Singapore's Engineering Stocks Poised for Growth in 2026 Amid Sector Shifts
    January 24, 2026, 4:36 AM EST. Singapore's engineering stocks, including leaders like ST Engineering and Seatrium, are emerging as potential hidden winners in 2026. Unlike high-growth tech or banking sectors, these firms offer long-term visibility and recurring earnings from defence, energy, marine engineering, and utilities. ST Engineering, with a record S$32.6 billion order book and S$14 billion new contracts in 9M2025, benefits from surging global defence spending and significant infrastructure investments by National Oil Companies in Asia Pacific and the Middle East. The sector faces lumpy earnings due to long business cycles, but structural shifts in offshore wind, hydrogen, and grid storage development offer steady growth prospects. Operational execution and order conversion remain key for these companies to realize earnings potential in 2026.
Go toTop